Literature DB >> 8862623

Holoprosencephaly: epidemiologic and clinical characteristics of a California population.

L A Croen1, G M Shaw, E J Lammer.   

Abstract

Holoprosencephaly is a brain defect resulting from incomplete cleavage of the embryonic forebrain. It involves forebrain and facial malformations that can range from mild to severe. The epidemiology of holoprosencephaly is largely unknown. Published prevalence estimates have been derived from clinic-based case series, and suggested risk factors for holoprosencephaly have been identified in case reports, without confirmation from systematically conducted population-based studies. Using data from a population-based birth defects registry in California, we describe the epidemiologic and clinical characteristics of cytogenetically and phenotypically distinct types of holoprosencephaly. A total of 121 cases was identified among a cohort of 1,035,386 live births and fetal deaths. The prevalence of holoprosencephaly was 1.2 per 10,000 births (95% confidence interval 1.0-1.4 per 10,000). Of all cases, 41% (50/121) had a chromosomal abnormality, most commonly Trisomy 13. Among the 71 cytogenetically apparently normal cases, 18 had recognizable syndromes and the remaining 53 were of unknown cause. Among the cytogenetically abnormal cases, females had a greater risk than males (odds ratio = 2.3,95% confidence interval [1.2, 4.4]). Among the cytogenetically normal cases, increased risks were observed among Hispanic whites (OR = 1.8 [0.9, 3.6]) and cases whose mother was born in Mexico (OR = 2.2 [1.0, 4.5]). Approximately 46% of all cases had alobar holoprosencephaly, the most severe form of the forebrain malformation. The facial phenotype did not strongly predict the severity of the brain defect; however, severity was inversely correlated with length of survival. This study is the first to present findings based on such a large population-based series of infants/fetuses affected by holoprosencephaly, and demonstrates the importance of investigating the component subgroups of this rare phenotype.

Entities:  

Mesh:

Year:  1996        PMID: 8862623     DOI: 10.1002/(SICI)1096-8628(19960823)64:3<465::AID-AJMG4>3.0.CO;2-O

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  32 in total

Review 1.  Prenatal diagnosis of de novo proximal interstitial deletion of 14q associated with cebocephaly.

Authors:  C P Chen; C C Lee; L F Chen; C Y Chuang; S W Jan; B F Chen
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

Review 2.  Cyclopia: an epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research.

Authors:  Iêda M Orioli; Emmanuelle Amar; Marian K Bakker; Eva Bermejo-Sánchez; Fabrizio Bianchi; Mark A Canfield; Maurizio Clementi; Adolfo Correa; Melinda Csáky-Szunyogh; Marcia L Feldkamp; Danielle Landau; Emanuele Leoncini; Zhu Li; R Brian Lowry; Pierpaolo Mastroiacovo; Margery Morgan; Osvaldo M Mutchinick; Anke Rissmann; Annukka Ritvanen; Gioacchino Scarano; Elena Szabova; Eduardo E Castilla
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-10-17       Impact factor: 3.908

3.  Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genes.

Authors:  Claude Bendavid; Christèle Dubourg; Isabelle Gicquel; Laurent Pasquier; Pascale Saugier-Veber; Marie-Renée Durou; Sylvie Jaillard; Thierry Frébourg; Bassem R Haddad; Catherine Henry; Sylvie Odent; Véronique David
Journal:  Hum Genet       Date:  2005-12-02       Impact factor: 4.132

4.  Three unusual but cytogenetically similar cases with up to five different cell lines involving structural and numerical abnormalities of chromosome 18.

Authors:  Isabel M Carreira; Alexandra Mascarenhas; Eunice Matoso; Ana B Couceiro; Lina Ramos; Andreas Dufke; Marie Mazauric; Rüdiger Stressig; Nadezda Kosyakova; Joana B Melo; Thomas Liehr
Journal:  J Histochem Cytochem       Date:  2007-06-26       Impact factor: 2.479

Review 5.  Holoprosencephaly and agnathia spectrum: Presentation of two new patients and review of the literature.

Authors:  Emily F Kauvar; Benjamin D Solomon; Cynthia J R Curry; Anthonie J van Essen; Nicole Janssen; Amalia Dutra; Erich Roessler; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

6.  Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals.

Authors:  Benjamin D Solomon; Felicitas Lacbawan; Sandra Mercier; Nancy J Clegg; Mauricio R Delgado; Kenneth Rosenbaum; Christèle Dubourg; Veronique David; Ann Haskins Olney; Lars-Erik Wehner; Ute Hehr; Sherri Bale; Aimee Paulussen; Hubert J Smeets; Emily Hardisty; Anna Tylki-Szymanska; Ewa Pronicka; Michelle Clemens; Elizabeth McPherson; Raoul C M Hennekam; Jin Hahn; Elaine Stashinko; Eric Levey; Dagmar Wieczorek; Elizabeth Roeder; Chayim Can Schell-Apacik; Carol W Booth; Ronald L Thomas; Sue Kenwrick; Derek A T Cummings; Sophia M Bous; Amelia Keaton; Joan Z Balog; Donald Hadley; Nan Zhou; Robert Long; Jorge I Vélez; Daniel E Pineda-Alvarez; Sylvie Odent; Erich Roessler; Maximilian Muenke
Journal:  J Med Genet       Date:  2009-12-02       Impact factor: 6.318

Review 7.  Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder.

Authors:  Shonagh K O'Leary-Moore; Scott E Parnell; Robert J Lipinski; Kathleen K Sulik
Journal:  Neuropsychol Rev       Date:  2011-03-29       Impact factor: 7.444

8.  Targeted disruption of Tgif, the mouse ortholog of a human holoprosencephaly gene, does not result in holoprosencephaly in mice.

Authors:  Jun Shen; Christopher A Walsh
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 9.  Holoprosencephaly: a paradigm for the complex genetics of brain development.

Authors:  E Roessler; M Muenke
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

10.  Magnetic resonance microscopy defines ethanol-induced brain abnormalities in prenatal mice: effects of acute insult on gestational day 7.

Authors:  Elizabeth A Godin; Shonagh K O'Leary-Moore; Amber A Khan; Scott E Parnell; Jacob J Ament; Deborah B Dehart; Brice W Johnson; G Allan Johnson; Martin A Styner; Kathleen K Sulik
Journal:  Alcohol Clin Exp Res       Date:  2009-10-23       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.